Shareholders' Equity (Deficiency) (Shareholders' Equity Activity) (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Schedule of Issued and Treasury Shares [Line Items]
Common Stock, Shares, Issued	72		71
Common Stock, Shares, Outstanding	72		71
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning balance	$ 551	$ 496
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	81	(74)
Noncontrolling Interest Dividends	(6)
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(43)	(4)
Other Comprehensive Income (Loss), Net of Tax	3
Balance, ending balance	586	426
Capital in Excess of Par Value
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning balance	2,928	2,904
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(43)	(4)
Balance, ending balance	2,885	2,908
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning balance	(2,371)	(2,397)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	72	(80)
Balance, ending balance	(2,299)	(2,477)
Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning balance	(22)	(35)
Other Comprehensive Income (Loss), Net of Tax	3
Balance, ending balance	(19)	(35)
Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning balance	16	24
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	9	6
Noncontrolling Interest Dividends	(6)
Balance, ending balance	$ 19	$ 30